Expression of RAD51, BRCA1 and P53 does not correlate with cellular radiosensitivity of normal human fibroblasts

Andrei V, Elena A (2003) The role of p53 in the determining sensitivity to radiotherapy. Nature 3:117–129 Leong T, Chao M, Bassal S, McKay M (2003) Radiation-hypersensitive cancer patients do not manifest protein expression abnormalities in components of the nonhomologous end-joining (NHEJ) pathway. Br J Cancer 88:1251–1255 Kasten U, Plottner N, Johansen J, Overgaard J, Dikomey E (1999) Ku70/80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts. Br J Cancer 79(7/8):1037–1041 Bentzen S, Overgaard J (1994) Patient to patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol 4:68–80 Turesson I, Nyman J, Holmberg E, Oden A (1996) Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 36:1065–1075 MaKay M, Peters L (1997) Genetic determinants of radiation response. Report on a symposium held at peter MacCallum Cancer Institute, Melbourne, Australia, 8 August 1996. Int J Radiat Biol 71:225–229 Leong T, Whitty J, Keilar M et al (2000) Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. Int J Radiat Oncol Biol Phys 48:959–965 Severin D, Leong T, Cassidy B et al (2001) Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients. Int J Radiat Oncol Biol Phys 50:1323–1331 Sak A, Stueben G, Groneberg M, Böcker W, Stuschke M (2005) Targeting of RAD51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines. Br J Cancer 92:1089–1097 Johnson R, Jasin M (2001) Double-strand break-induced homologous recombination in mammalian cells. Biochem Soc Trans 29:196–201 Jasin M (2002) Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 21:8981–8993 Thomas L, Luca P, Ashok R, Tom L (2003) Sequence fingerprints in BRCA2 and RAD51: implications for DNA repair and cancer. DNA Repair 2:1015–1028 Sonoda E, Takada M, Yamashita Y, Morrison C, Takeda S (2001) Homologous DNA recombination in vertebrate cells. Proc Natl Acad Sci 98(15):8388–8394 Venkitaraman A (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171–182 Griffin C, Simpson P, Wilson C, Thacker J (2000) Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol 2(10):757–761 Takata M, Sasaki M, Sonada E et al (2000) The Rad51 paralog Rad 51B promotes homologous recombinational repair. Mol Cell Biol 20(17):6476–6482 Takata M, Sasaki M, Tachiri S et al (2001) Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol 21(8):2858–2866 Patel K, Vu V, Lee H et al (1998) Involvement of Brca2 in DNA repair. Mol Cell 1:347–357 Connor F, Bertwiste D, Mee P et al (1997) Tumorigenesis and a DNA repair defect in mice with a truncating BRCA2 mutation. Nat Genet 17:423–430 Hakem R, de la Pompa J, Sirard C et al (1996) The tumour suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009–1023 Suzuki A, de la Pompa J, Hakim R et al (1997) BRCA2 is required for embryonic cellular proliferation in the mouse. Genes Dev 11:1242–1252 Xu X, Qiao W, Linke S et al (2001) Genetic interactions between suppressors BRCA1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet 28:266–271 Henning W, Ellen E, Biao W et al (2000) Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene 19:632–639 Duddenhöffer C, Rohaly G, Will K, Deppert W, Wiesmüller L (1998) Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol Cell Biol 18:5332–5342 Bertrand P, Rouillard D, Boulet A, Vealois C, Soussi T, Lopez B (1997) Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 14:1117–1122 Mekeel K, Tang W, Kachnic Lluo C, Defrank J, Powell S (1997) Inactivation of p53 results in high rates of homologous recombination. Oncogene 14:1847–1857 Lane D (1992) p53, guardian of the genome. Nature 358:15–16 El-Awady R, Mahmoud M, Saleh E et al (2005) No correlation between radiosensitivity or DSB repair capacity of normal fibroblasts and acute normal tissue reaction after radiotherapy of breast cancer patients. Int J Rad Biol 81(7):501–508 El-Awady R, Dikomey E, Dahm-Daphi J (2003) Radiosensitivity of human tumour cells is correlated with the induction but not with the repair of DNA double-strand breaks. Br J Cancer 89:593–600 Jackson S (2002) Sensing and repairing DNA double strand breaks. Carcinogenesis 23(5):687–696 Fernet N, Hall J (2004) Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair 3:1237–1243 Sonoda E, Sasaki M, Buerstedde J et al (1998) RAD51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J 17:598–608 Carlomagno F, Burnet N, Turesson I et al (2000) Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities. Int J Cancer 85(6):845–849 Raderschall E, Bazarov A, Cao J et al (2002) Formation of higher-order nuclear RAD51 structures are functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J Cell Sci 115:153–164 Djuzenova C, Mühl B, Schakowski R, Oppitz U, Flentje M (2004) Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients. Br J Cancer 90:2356–2363 Moynahan M, Cui T, Jasin M (2001) Homology-directed DNA repair, mitomycin-C resistance, and chromosome stability is restored with correction of a BRCA1 mutation. Cancer Res 61:4842–4850 Li S, Ting N, Zheng L et al (2000) Functional link of BRCA1 and ataxia telangiestasia gene product in DNA damage response. Nature 406:210–215 Wang Y, Cortez D, Yazadi P, Neff N, Elledge S, Qin J (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14:927–939 Pierce L, Strawderman M, Narod S et al (2000) Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18:360–3369 Vogelstein B, Lane D, Levine A (2000) Surfing the p53 network. Nature 408:307–310 Graeber T, Peterson J, Tsai M, Monica K, Fomace A, Giaccia A (1994) Hypoxia induces accumulation of p53 protein, but activation of G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14:6264–6277 Appella E, Anderson C (2001) Post translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268:2764–2772 Clifford B, Beljin M, Stark G, Taylor W (2003) G2 arrest in response to topoisomerase 11 inhibitors: the role of p53. Cancer Res 63:4074–4081 Essmann F, Engels I, Totzke G, Schulze-Osthoff K, Jänicke R (2004) Apoptosis resistance of MCF7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable events. Cancer Res 64:7065–7072 Böhnke A, Westphal F, Schmidt A, El-Awady R, Dahm-Daphi J (2004) Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells. Int J Radiat Biol 80(1):53–63